NCT00006185View on ClinicalTrials.gov

Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1999

Study Completion Date

August 31, 2003

Conditions
HIV InfectionsLipodystrophyInsulin Resistance
Interventions
DRUG

Avandia administration for 6-12 weeks

Trial Locations (1)

11794

University Hospital at Stony Brook New York, Stony Brook

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00006185 - Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome | Biotech Hunter | Biotech Hunter